With the raising of “omics’’ technologies, other biomarkers for PCa detection have been proposed, such as prostate cancer antigen 3 (PCA3), which is a biomarker coming from transcriptomic methodologies. This evidence concerns the gene PCA3 and posterior cortical atrophy.